质子泵抑制剂与H2受体拮抗剂对99mTc-MIBI心肌灌注显像胃壁摄取的影响
PPI组SWU发生率为36%,显著高于对照组8%、H2A组10.5%和干预组9.5%。腺苷负荷患者SWU发生率(26/116)显著高于运动负荷患者(1/40,P=.020)。
要点
- PPI组临床相关SWU发生率为36%,显著高于对照组8%、H2A组10.5%及停用PPI 3天组9.5%。
- 腺苷负荷患者SWU发生率为26/116,显著高于运动负荷患者的1/40(P=.020)。
- 使用PPI且拟行血管扩张剂负荷MPI的患者可停用PPI 3天或换用H2A以减少SWU。
核心结论
- PPI使用与99mTc-MIBI MPI中临床相关胃壁摄取增加相关,停用PPI 3天或换用H2A可降低其发生率。
主要发现
- 临床相关SWU发生率:PPI组36%,对照组8%,H2A组10.5%,干预组9.5%,组间差异有统计学意义。
- 运动负荷患者临床相关SWU发生率为1/40,腺苷负荷患者为26/116(P=.020)。
临床怎么用
- 使用PPI且拟行血管扩张剂负荷MPI的患者,可考虑停用PPI 3天或换用H2A以减少临床相关SWU。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stomach wall uptake (SWU) of tracer in 99mTc-MIBI myocardial perfusion imaging (MPI) occasionally leads to imaging artifacts, thereby lowering the diagnostic accuracy. It is less-studied phenomenon for possible link with proton pump inhibitors (PPIs) intake. This prospective work looked for association of SWU with PPI intake and compared its incidence with H2 antagonists (H2A) users and patients not on either gastroprotective medication. METHODS: One hundred fifty-six patients undergoing one day stress/rest 99mTc-MIBI SPECT-MPI were distributed into four groups: control group (n = 48, not on any gastroprotective medication), PPI group (n = 47, on PPI treatment), H2A group (n = 19, on H2A therapy), and intervention group (N = 42, PPI discontinued for 3 days before MPI). Poststress planar images were analyzed for clinically relevant SWU. RESULTS: Clinically relevant SWU was seen in 36% of PPI group patients compared to 8% in the control group, 10.5% in the H2A group, and 9.5% in the intervention group, respectively, with statistically significant difference. Only 1/40 patients undergoing exercise stress showed clinically relevant SWU compared to 26/116 patients undergoing adenosine stress (P = .020). CONCLUSION: Patients on PPIs scheduled for vasodilator stress MPI may discontinue PPIs for 3 days, or replace with H2A to reduce the incidence of clinically relevant SWU associated with PPI therapy.
引用
- Singh H, Mittal BR, Sood A, et al. Association of use of proton pump inhibitors and H2 antagonists with stomach wall uptake in 99mTc-methoxy-isobutyl-isonitrile (MIBI) myocardial perfusion imaging. J Nucl Cardiol. 2019. PMID: 31087263. doi:10.1007/s12350-019-01733-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。